Comparing Amla (Emblica Officinalis) and 3% Sodium Hypochlorite Against Enterococcus Faecalis in Root Canal Treatment: A Randomized Controlled Trial
"Comparative Antibacterial Evaluation of Emblica Officinalis and 3% Sodium Hypochlorite, Against Enterococcus Faecalis, as Root Canal Irrigants in Non-surgical Root Canal Treatment of Mature Single Rooted Anterior Teeth - A Randomized Controlled Trial."
1 other identifier
interventional
66
1 country
1
Brief Summary
Bacteria inside the root canal are a major cause of tooth infections. If they are not completely removed, the infection may continue even after root canal treatment. One bacterium, Enterococcus faecalis, is commonly found in persistent root canal infections. The goal of root canal treatment is to remove these bacteria and prevent the infection from returning. Along with cleaning the canal using dental instruments, dentists use disinfecting solutions (called irrigants) to kill remaining bacteria. The most commonly used irrigant is 3% sodium hypochlorite. Although it is effective at killing bacteria, it can irritate tissues, cause allergic reactions, has an unpleasant smell and taste, and may weaken the tooth. Because of these disadvantages, researchers are exploring safer natural alternatives. Amla (Emblica officinalis) is a medicinal plant known for its antibacterial, anti-inflammatory, and pain-relieving properties. This study aims to compare amla with 3% sodium hypochlorite to determine how well each reduces Enterococcus faecalis during root canal treatment and whether they produce similar clinical outcomes. The study will include 66 patients aged 14-50 years who require root canal treatment for an infected single-rooted front tooth. Participants will be randomly assigned to one of two groups: one will receive 3% sodium hypochlorite, and the other will receive amla as the root canal irrigant. Bacterial samples will be collected before treatment, immediately after cleaning the canal, and one week later. The number of bacteria will be measured and compared between the two groups. The researchers will also assess pain, tenderness, and other signs of healing after treatment. The findings will help determine whether amla is a safe and effective natural alternative to the standard root canal irrigant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedJuly 7, 2026
June 1, 2026
1 month
June 30, 2026
June 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in Enterococcus faecalis bacterial count (CFU/mL)
Change in the number of Enterococcus faecalis colony-forming units (CFU/mL) recovered from root canal samples collected before treatment, immediately after irrigation, and 7 days after treatment, comparing 3% sodium hypochlorite and Emblica officinalis irrigation.
Baseline, immediately after irrigation, and 7 days after treatment.
Study Arms (2)
3% Sodium Hypochlorite Irrigation ( Control)
ACTIVE COMPARATORParticipants assigned to this arm will undergo non-surgical root canal treatment using 3% sodium hypochlorite as the root canal irrigant. Following access cavity preparation and working length determination, the root canal will be instrumented using K-files. A total of 6 mL of 3% sodium hypochlorite will be used for irrigation during canal preparation and shaping. Microbiological samples will be collected before instrumentation (S1), immediately after instrumentation and irrigation (S2), and one week later (S3) to evaluate the reduction in Enterococcus faecalis colony-forming units (CFU/mL). Clinical outcomes, including pain on percussion, tenderness on palpation, and the presence of a sinus tract, will also be assessed.
Emblica officinalis (Amla) Irrigation (Experimental)
EXPERIMENTALParticipants assigned to this arm will undergo non-surgical root canal treatment using Emblica officinalis (Amla) as the root canal irrigant. Following access cavity preparation and working length determination, the root canal will be instrumented using K-files. A total of 6 mL of Emblica officinalis solution will be used for irrigation during canal preparation and shaping. Microbiological samples will be collected before instrumentation (S1), immediately after instrumentation and irrigation (S2), and one week later (S3) to evaluate the reduction in Enterococcus faecalis colony-forming units (CFU/mL). Clinical outcomes, including pain on percussion, tenderness on palpation, and the presence of a sinus tract, will also be assessed.
Interventions
A total of 6 mL of 3% sodium hypochlorite will be used as the root canal irrigant during cleaning and shaping in non-surgical root canal treatment.
A total of 6 mL of Emblica officinalis (Amla) solution will be used as the root canal irrigant during cleaning and shaping in non-surgical root canal treatment.
Eligibility Criteria
You may qualify if:
- Co-operative patients of both sexes aged between 18-50 years
- Patients belonging to ASA classification I and II (mild to moderate systemic disease).
- Permanent mature single-rooted and single canal teeth.
- Patients with pulp necrosis / apical periodontitis (primary endodontic infection with periapical radiolucency) will be included.
- Adequate crown structure.
- Probing level \</= 3mm
- Patients not taking antibiotics for the last two weeks (pragmatic approach).
You may not qualify if:
- ●Patients with ASA Classification III, IV, V and VI or any other congenital disease.
- Patient with liver failure and patient on blood thinning medication will be excluded.
- Teeth with Multiple roots and canals.
- Teeth with calcified pulp chamber.
- Teeth with previous endodontic therapy performed.
- Aberrant anatomy.
- Teeth associated with vertical root fracture and coronal perforation.
- Patient taking antibiotics in the last two weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Punjab Dental Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 30, 2026
First Posted
July 7, 2026
Study Start
July 1, 2026
Primary Completion
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
July 7, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Undecided Confidentiality